Product NDC: | 0264-1909 |
Proprietary Name: | NephrAmine |
Non Proprietary Name: | HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, and SODIUM BISULFITE |
Active Ingredient(s): | .014; .25; .56; .88; .64; .88; .88; .4; .2; .64 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL & nbsp; HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, and SODIUM BISULFITE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0264-1909 |
Labeler Name: | B. Braun Medical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017766 |
Marketing Category: | NDA |
Start Marketing Date: | 19780224 |
Package NDC: | 0264-1909-55 |
Package Description: | 12 CARTON in 1 CASE (0264-1909-55) > 1 CONTAINER in 1 CARTON > 250 mL in 1 CONTAINER |
NDC Code | 0264-1909-55 |
Proprietary Name | NephrAmine |
Package Description | 12 CARTON in 1 CASE (0264-1909-55) > 1 CONTAINER in 1 CARTON > 250 mL in 1 CONTAINER |
Product NDC | 0264-1909 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, and SODIUM BISULFITE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19780224 |
Marketing Category Name | NDA |
Labeler Name | B. Braun Medical Inc. |
Substance Name | CYSTEINE HYDROCHLORIDE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; THREONINE; TRYPTOPHAN; VALINE |
Strength Number | .014; .25; .56; .88; .64; .88; .88; .4; .2; .64 |
Strength Unit | g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
Pharmaceutical Classes |